Boothbay Fund Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-9,688
| Closed | -$109K | – | 2243 |
|
|
2022
Q2 | $109K | Sell |
9,688
-16,327
| -63% | -$184K | ﹤0.01% | 1696 |
|
|
2022
Q1 | $778K | Buy |
26,015
+21,041
| +423% | +$629K | 0.02% | 843 |
|
|
2021
Q4 | $132K | Sell |
4,974
-1,678
| -25% | -$44.5K | ﹤0.01% | 1485 |
|
|
2021
Q3 | $241K | Sell |
6,652
-194
| -3% | -$7.03K | 0.01% | 1233 |
|
|
2021
Q2 | $297K | Buy |
6,846
+3,214
| +88% | +$139K | 0.01% | 1136 |
|
|
2021
Q1 | $124K | Sell |
3,632
-4,873
| -57% | -$166K | ﹤0.01% | 1217 |
|
|
2020
Q4 | $298K | Sell |
8,505
-12,377
| -59% | -$434K | 0.01% | 798 |
|
|
2020
Q3 | $501K | Sell |
20,882
-2,403
| -10% | -$57.7K | 0.03% | 546 |
|
|
2020
Q2 | $426K | Buy |
23,285
+1,580
| +7% | +$28.9K | 0.03% | 521 |
|
|
2020
Q1 | $339K | Buy |
21,705
+15,344
| +241% | +$240K | 0.03% | 460 |
|
|
2019
Q4 | $136K | Buy |
+6,361
| New | +$136K | 0.01% | 632 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 761 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 742 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 723 |
|
|
2016
Q4 | – | Sell |
-1,516
| Closed | -$56K | – | 823 |
|
|
2016
Q3 | $56K | Sell |
1,516
-1,567
| -51% | -$57.9K | 0.01% | 596 |
|
|
2016
Q2 | $69K | Sell |
3,083
-78
| -2% | -$1.75K | 0.03% | 433 |
|
|
2016
Q1 | $66K | Buy |
3,161
+704
| +29% | +$14.7K | 0.05% | 227 |
|
|
2015
Q4 | $74K | Buy |
2,457
+750
| +44% | +$22.6K | 0.03% | 479 |
|
|
2015
Q3 | $42K | Buy |
1,707
+571
| +50% | +$14K | 0.02% | 411 |
|
|
2015
Q2 | $36K | Hold |
1,136
| – | – | 0.01% | 329 |
|
|
2015
Q1 | $41K | Buy |
+1,136
| New | +$41K | 0.03% | 279 |
|